Since METTL17 knockdown alone inhibited the growth of SW620 xenograft tumors in vivo and sensitized CRC cells to GPX4 inhibition in vitro, we further investigated the therapeutic potential of combined METTL17 inhibition and ferroptotic induction for CRC treatment. Here, METTL17 is linked to colorectal carcinoma.